Men's Weekly

.

Business Telegraph

.

Hardman & Co Life Sciences Research: Long-term pharmaceutical industry cost and EBIT analysis

  • Written by Telegraph Magazine
LONDON, UK - EQS Newswire - 10 June 2022 - Financial information from over 100 multinational drug companies, involving over 70,000 data points, have been accumulated over the past 35 years to create a pharmaceutical database.

All our data (sales, COGS, SG&A, R&D and other income) have been derived from annual reports, regulatory filings and company presentations, and then analysed, wherever possible, in a like-for-like manner, irrespective of how each company presents the data. This is a key differentiator to competitive products and is important because all company management teams report "adjusted", "core", or "non-GAAP" earnings to show themselves in the best possible light. However, different inclusion/exclusion criteria in the generation of these adjustments lead to distortions and variability.

Although some of the companies are multi-divisional, another key differentiator is the extraction and analysis of data for the pharmaceutical segment only. This product is unique because it analyses the individual cost components of each company over time and generates pharma industry weighted averages, allowing peer and industry comparisons to be made. It also generates individual company and industry-wide underlying operating profit (EBIT), both pre-R&D and post R&D.

Historically, data from over 100 companies has been accumulated, but industry consolidation means that just 40 are included currently, which command an estimated 76% of the global drug industry. The main exceptions are the Chinese companies where insufficient data are available on a consistent basis.

Current companies included in dataset:

pharma.png

Click here to find out more:
https://hardmanandco.com/2021-pharma-statistics-long-term-cost-underlying-ebit-analysis/

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259. Attention is drawn to the important disclaimers at the end of the report.

Entrepreneurs & Leaders

How to Blend Indoor and Outdoor Spaces Seamlessly

Creating a natural flow between your indoor and outdoor spaces can make your home feel larger, brighter, and more inviti...

Embracing Change in Business: Turning Challenge into Opportunity with the Help of a Business Mentor

In today’s fast-paced, unpredictable and ever-changing business world, change in business is not just inevitable – it’...

Why Hiring a Digital Marketing Agency in Sydney Is a Smart Move for Growing Brands

In the competitive world of online marketing, standing out in a crowded digital space is no easy task. Businesses acro...

Boss Air Suspension and Superior Engineering: Advanced Suspension Technologies

The evolution of 4WD suspension reaches new heights with systems from Boss Air Suspension and Superior Engineering. Th...

What to Look for When Replacing Outdated Hose Fittings in Your Production Line

Over time, even the most robust equipment starts to show wear, and one of the most overlooked yet vital components in th...

Why Promotional Products Still Matter in a Digital World in Australia

In an age dominated by digital marketing, tangible branded merchandise still holds significant power. Promotional prod...

Wang Chuanfu Attends BYD Harmony’s 100th Overseas Store Opening

                                                                 Dignitaries inaugurate the new storeOn July 12, 2025, M...

A Step-by-Step Guide on How to Open Company in Poland

Poland continues to be a highly attractive destination for global entrepreneurs seeking new opportunities within the E...

What Sets a Top Commercial Plasterer Contractor Apart in Melbourne’s Competitive Market

Melbourne’s commercial construction scene moves fast. Whether it is a retail space on Chapel Street, a high-rise offic...